|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
90,000,000 |
Market
Cap: |
1.70(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$18.88 - $18.88 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Latham John A |
Chief Scientific Officer |
|
2018-08-01 |
4 |
OE |
$3.47 |
$86,622 |
D/D |
24,999 |
268,692 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2018-07-02 |
4 |
AS |
$15.49 |
$188,364 |
D/D |
(12,161) |
831 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2018-07-02 |
4 |
OE |
$0.99 |
$16,739 |
D/D |
12,161 |
12,992 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2018-07-02 |
4 |
AS |
$15.48 |
$387,002 |
D/D |
(24,999) |
243,693 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2018-07-02 |
4 |
OE |
$3.47 |
$86,622 |
D/D |
24,999 |
268,692 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2018-06-01 |
4 |
AS |
$17.81 |
$217,127 |
D/D |
(12,161) |
831 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2018-06-01 |
4 |
OE |
$0.99 |
$16,739 |
D/D |
12,161 |
12,992 |
|
- |
|
Litton Mark James |
Chief Business Officer |
|
2018-06-01 |
4 |
AS |
$17.74 |
$405,412 |
D/D |
(22,727) |
102,189 |
|
- |
|
Litton Mark James |
Chief Business Officer |
|
2018-06-01 |
4 |
OE |
$0.99 |
$22,500 |
D/D |
22,727 |
124,916 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2018-06-01 |
4 |
AS |
$17.76 |
$446,356 |
D/D |
(24,999) |
243,693 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2018-06-01 |
4 |
OE |
$3.47 |
$109,121 |
D/D |
24,999 |
268,692 |
|
- |
|
Benedict Larry |
EVP and PAO |
|
2018-05-31 |
4 |
A |
$9.35 |
$12,333 |
D/D |
1,319 |
33,453 |
|
- |
|
Bucher James B |
Sr. VP & General Counsel |
|
2018-05-31 |
4 |
A |
$9.35 |
$18,700 |
D/D |
2,000 |
3,623 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2018-05-16 |
4 |
AS |
$15.03 |
$182,758 |
D/D |
(12,161) |
831 |
|
- |
|
Smith Jeffrey T L |
Managing Director |
|
2018-05-16 |
4 |
OE |
$0.99 |
$16,739 |
D/D |
12,161 |
12,992 |
|
- |
|
Bucher James B |
Sr. VP & General Counsel |
|
2017-11-30 |
4 |
A |
$9.35 |
$15,175 |
D/D |
1,623 |
1,623 |
|
- |
|
Latham John A |
Chief Scientific Officer |
|
2017-11-30 |
4 |
A |
$9.35 |
$4,413 |
D/D |
472 |
243,208 |
|
- |
|
Litton Mark James |
Chief Business Officer |
|
2017-11-13 |
4 |
AS |
$10.80 |
$178,486 |
D/D |
(16,519) |
99,932 |
|
- |
|
Litton Mark James |
Chief Business Officer |
|
2017-11-13 |
4 |
OE |
$1.65 |
$27,256 |
D/D |
16,519 |
116,451 |
|
- |
|
Siegall Clay B |
Director |
|
2017-11-01 |
4 |
OE |
$0.99 |
$35,496 |
D/D |
27,270 |
31,714 |
|
- |
|
Litton Mark James |
Chief Business Officer |
|
2017-10-16 |
4 |
AS |
$12.33 |
$203,703 |
D/D |
(16,520) |
99,932 |
|
- |
|
Litton Mark James |
Chief Business Officer |
|
2017-10-16 |
4 |
OE |
$1.65 |
$27,258 |
D/D |
16,520 |
116,452 |
|
- |
|
Dow Stephen M |
Director |
|
2017-07-18 |
4 |
B |
$10.00 |
$250,000 |
I/I |
25,000 |
307,190 |
2.1 |
- |
|
Yarno Wendy L |
Director |
|
2017-07-18 |
4 |
B |
$10.00 |
$50,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
Smith Jeffrey T L |
Sr. VP Translational Medicine |
|
2017-06-20 |
4 |
AS |
$20.00 |
$11,700 |
D/D |
(585) |
831 |
|
- |
|
296 Records found
|
|
Page 3 of 12 |
|
|